Outcomes of Renal Replacement in Mexico

NCT07474805 | Not Yet Recruiting

• 1 other identifier: NMM-5533-25-28-1
• Study Type: observational
• Target: 290
• Locations: 0 countries
• Sites: N/A

Brief Summary

A descriptive, observational, prospective, multicenter study aimed at describing the main clinical outcomes of patients with chronic kidney disease receiving any form of renal replacement therapy in Mexico.

Conditions

Chronic Kidney Disease - Stage V; Chronic Kidney Disease on Hemodialysis

Keywords

Chronic kidney disease; Renal replacement therapy; Clinical outcomes

Outcome Measures

Primary Outcomes (1)

• All-cause mortality

  The occurrence of death from any cause during the follow-up period, as documented in the patient's medical record

  From enrollment in the study until death from any cause or end of follow-up, assessed up to 3 years.

Secondary Outcomes (2)

• Hospitalizations per patient-year

  From enrollment until the end of follow-up, assessed up to 3 years

• Infection rate

  From enrollment until the end of follow-up, assessed up to 3 years

Study Arms (1)

CKD on RRT

Patients with chronic kidney disease undergoing renal replacement therapy (RRT) in Mexico

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with chronic kidney disease undergoing hemodialysis or peritoneal dialysis in the units participating in the project

You may qualify if:

• Willingness to participate and provision of written informed consent
• Diagnosis of chronic kidney disease and treatment with hemodialysis or peritoneal dialysis for ≥3 months
• Availability of a medical record containing information on the study variables
• Receiving care at one of the participating centers

You may not qualify if:

• Life expectancy \<3 months due to a cause unrelated to chronic kidney disease

Sponsors & Collaborators

• Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran: lead

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Olynka Vega Vega, MD, MSc

CONTACT

+5215548039428; olynkavega@hotmail.com

Yazmin Alejandra Mercado Hernandez, MD

CONTACT

+5215520353821; yazale1992@hotmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 3 Years
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Attending Physician, Department of Nephrology

Study Record Dates

• First Submitted: March 9, 2026
• First Posted: March 16, 2026
• Study Start: April 1, 2026
• Primary Completion: April 1, 2026
• Study Completion (Estimated): April 1, 2029
• Last Updated: March 16, 2026

Record last verified: 2026-03